ECM Weekly (24 May 2020) - NetEase and JD Homecoming, Legend Biotech, Nongfu Spring, Yeahka
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. The talk...
194 Views
Legend Biotech IPO Initiation: Choosing Therapies À La CAR-T
Legend Biotech (BLG US) is one of the leading companies in developing CAR-T cell therapies in China, having received clearance for the first CAR-T...
142 Views
BBI Life: Scheme Doc Out, IFA Ekes Out A Fair Opinion
Back on the 20 January, BBI Life Sciences (1035 HK), the largest supplier of DNA synthesis products in the PRC, announced a privatisation Offer by...
321 Views
BBI Life: Privatisation Offer For DNA Synthesizer
Following a brief trading halt, BBI Life Sciences (1035 HK), the biggest supplier of DNA synthesis products in the PRC, announced a privatisation...
587 Views
Trade Risks Start to Impact, as China Biotech Ambitions Grow…
Cyclical indicators are softening this month - new orders index for the Philly Fed fell nearly 23 points while Japan’s PMI new export orders...
126 Views